Cardiomyopathy: Clinical Trials

10 trials for Cardiomyopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 10
Phase 25Completed 5

Follow Cardiomyopathy: new trials by email Literature Review of Cardiomyopathy trials Research Report on Cardiomyopathy

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
Test formulation of HRS-1893 tablet, Reference formulation of HRS-1893 tablet - Cardiomyopathy
Phase 1CompletedShandong Suncadia Medicine Co., Ltd.582026-04-142026-09-21
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
HRS-1893 tablet A, HRS-1893 tablet B - Cardiomyopathy
Phase 1CompletedShandong Suncadia Medicine Co., Ltd.382025-12-112026-04-02
Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population
Inhaled nebulized milrinone - Heart Failure, Cardiomyopathy
Phase 1CompletedUniversity of Kansas Medical Center102020-06-152024-09-19
Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia
stereotactic body radiotherapy (SBRT) - Ventricular Tachycardia, Cardiomyopathy
Phase 1 / Phase 2CompletedWashington University School of Medicine192016-07-012024-08-21
Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines
Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell Transplantation - Cardiomyopathy, Heart Failure
Phase 1CompletedM.D. Anderson Cancer Center72016-01-112022-05-17
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Tolvaptan 30 mg + IV Diuretics, Metolazone 5 mg + IV Diuretics, 2.5 times the Diuretics Dose - Cardiomyopathy, Congestive Heart Failure
Phase 1CompletedEmory University142016-01-012019-03-27
Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)
Tadalafil, Placebo - Cardiomyopathy, Renal Impairment
Phase 1 / Phase 2CompletedMayo Clinic222014-03-012020-10-28
Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
Tadalafil, Placebo - Cardiomyopathy, Renal Impairment
Phase 1 / Phase 2CompletedMayo Clinic202014-01-092021-06-11
Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy
Mono Nuclear Cell (MNC) transplantation - Cardiomyopathy
Phase 1 / Phase 2CompletedNasser Aghdami MD., PhD302013-06-012017-04-27
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
B-type Natriuretic Peptide (BNP), Placebo - Congestive Heart Failure, Cardiomyopathy
Phase 1 / Phase 2CompletedHorng Chen452000-01-012012-12-20

Narrower conditions

Cardiomyopathies (10)  ·  Heart Failure (4)  ·  Renal Insufficiency (2)  ·  Respiratory Aspiration (1)  ·  Tachycardia, Ventricular (1)  ·  Ventricular Premature Complexes (1)

Broader conditions

Cardiovascular Diseases (10)  ·  Heart Diseases (10)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Arrhythmias, Cardiac (1)  ·  Cardiac Complexes, Premature (1)  ·  Cardiac Conduction System Disease (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)

Interventions

Tadalafil (2)  ·  Diuretics (1)  ·  Furosemide (1)  ·  Mesenchymal Stem Cell Transplantation (1)  ·  Metolazone (1)  ·  Natriuretic Peptide, Brain (1)  ·  Radiosurgery (1)  ·  Standard of Care (1)  ·  Tablets (1)  ·  Tolvaptan (1)  ·  Transplantation (1)

Sponsors

Mayo Clinic (2)  ·  Shandong Suncadia Medicine Co., Ltd. (2)  ·  Emory University (1)  ·  Horng Chen (1)  ·  M.D. Anderson Cancer Center (1)  ·  Nasser Aghdami MD., PhD (1)  ·  University of Kansas Medical Center (1)  ·  Washington University School of Medicine (1)

Countries

United States (7)  ·  China (2)  ·  Iran (1)

Top investigators

Horng H Chen, MD (2)  ·  Amanda Olson (1)  ·  Divya Gupta, MD (1)  ·  Hamid Gourabi, PhD (1)  ·  Horng H. Chen, M.D. (1)  ·  Koorosh Vahidshahi, MD (1)  ·  Mohammad Mahdavi, MD (1)  ·  Nasser Aghdami, MD,PhD (1)  ·  Phillip Cuculich, MD (1)  ·  Zachary L Cox, PharmD (1)  ·  Zubair Shah, MD (1)

Results publications

PMID 23122795, PMID 30586734, PMID 35001638, PMID 37295665, PMID 37871843

NIH funding

P01HL076611 (1), R01HL036634 (1), R01HL084155 (1), UL1RR024150 (1)